Vol 2 (March 2017): Journal of Xiangya Medicine

Editorial
Are we failing in hip protrusio treatment?
Alessandro Aprato, Claudia Galletta, Alessandro Bistolfi, Alessandro Mass
Journal of Xiangya Medicine  
2017;
2:
33  
Editorial
Targeting intra-tumoral lactic acidosis in hepatocellular carcinoma: a long way to go
Jemima Finkel, Emmanuel A. Tsochatzis
Journal of Xiangya Medicine  
2017;
2:
32  
Editorial
Gab1, a therapeutic target for allergic asthma?
Danh C. Do, Arshi Agrawal, Xiaoyan Luo, Peisong Gao
Journal of Xiangya Medicine  
2017;
2:
31  
Editorial
Femoroacetabular impingement following an osteotomy for acetabular dysplasia: a commentary on a recently published study
Alexander H. Jinnah, Riyaz H. Jinnah
Journal of Xiangya Medicine  
2017;
2:
30  
Editorial
Targeting the extracellular scavenger DNASE1L3 on SLE
Li Wang, Wentao Mi, Quan-Zhen Li
Journal of Xiangya Medicine  
2017;
2:
29  
Editorial
Effects of testosterone therapy on prostate cancer
Alan L. Kaplan
Journal of Xiangya Medicine  
2017;
2:
28  
Editorial
Third-line treatment options for refractory urgency urinary incontinence in women—a commentary to ROSETTA trial
Pawel Miotla, Tomasz Rechberger
Journal of Xiangya Medicine  
2017;
2:
27  
Editorial
An inconvenient truth: at least three prostate-specific antigen-based screening cycles are needed to reduce subsequent prostate cancer incidence
Hiromichi Iwamura, Takuma Narita, Shingo Hatakeyama
Journal of Xiangya Medicine  
2017;
2:
26  
Letter to the Editor
Dp71 as a tumor suppressor: combined efforts of nuclear lamin B1 and emerin?
Sipin Tan, Xianzhong Xiao
Journal of Xiangya Medicine  
2017;
2:
25